ClinicalTrials.Veeva

Menu

Spot Ex PMCF 01 Study

Laborie Medical Technologies logo

Laborie Medical Technologies

Status

Invitation-only

Conditions

Presence of Spot Ex Endoscopic Marker

Treatments

Other: Endoscopic marker

Study type

Observational

Funder types

Industry

Identifiers

NCT07206615
CLN-00082

Details and patient eligibility

About

Post market clinical study that is a chart review of the Spot Ex Endoscopic Marker

Full description

This study is a medical chart review to confirm the safety and performance of the Spot Ex Endoscopic Marker in accordance with the approved labelling/instructions for use (IFU).

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who had a marking in their GI tract with the Spot Ex Endoscopic marker for the purposes of clinical surveillance.

Exclusion criteria

  • 1. Patients who had the marked tissue resected less than 3 years after initial marking.
  • 2. Inadequate medical documentation to ascertain visualization of the marking.
  • 3. Inability to visualize or image the marking due to poor colonoscopy preparation.
  • 4. Patients considered as Vulnerable Populations, as defined in CFR - Code of Federal Regulations Title 21

Trial design

60 participants in 1 patient group

Spot Ex Endoscopic Marker
Description:
Subjects with Spot Ex Endoscopic Marker present 36 months post-tattoo
Treatment:
Other: Endoscopic marker

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems